Hostname: page-component-cd9895bd7-dk4vv Total loading time: 0 Render date: 2024-12-28T03:37:24.165Z Has data issue: false hasContentIssue false
  • English
  • Français

Neuroleptic Malignant Syndrome Presenting as Hyperosmolar Non-ketotic Diabetic Coma

Published online by Cambridge University Press:  02 January 2018

M. Balzan  and
J. M. Cacciottolo
M. Balzan
Affiliation:
Department of Medicine, St Luke's Hospital, Malta
J. M. Cacciottolo
Affiliation:
Department of Medicine, St Luke's Hospital, Malta
Get access Rights & Permissions [Opens in a new window]

Abstract

A 50-year-old man presented with hyperosmolar nonketotic diabetic coma associated with the neuroleptic malignant syndrome (NMS) after intramuscular treatment with haloperidol. It is suggested that NMS may occur as a complication of uncontrolled diabetes mellitus with dehydration. Conversely, NMS might precipitate diabetic coma in patients with previously well controlled blood glucose.

Type
Brief Reports
Information
The British Journal of Psychiatry , Volume 161 , Issue 2 , August 1992 , pp. 257 - 258
Copyright
Copyright © 1992 The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Caroff, S. N. (1980) The neuroleptic malignant syndrome. Journal of Clinical Psychiatry, 41, 79–83.Google Scholar
Harsh, H. H. (1987) Neuroleptic malignant syndrome. Physiological and laboratory findings in a series of 9 cases. Journal of Clinical Psychology, 48, 328–333.Google Scholar
Itoh, H., Ohtsuka, N., Ogita, K., et al (1977) Malignant neuroleptic syndrome, its present status in Japan and clinical problems. Folia Psychiatrica et Neurologica Japan, 31, 567–576.Google ScholarPubMed
Keck, P. E. Jr., Pope, H. G., Cohen, B. M., et al (1989) Risk factors in neuroleptic malignant syndrome. Archives of General Psychiatry, 46, 914–918.Google Scholar
Pope, H. C., Keck, P. E. Jr, McElroy, S. L., et al (1986) Frequency and prevention of neuroleptic malignant syndrome in a large psychiatric hospital. American Journal of Psychiatry, 143, 1227–1233.Google Scholar
Smego, R. A. & Durack, D. T. (1982) The neuroleptic malignant syndrome. Archives of Internal Medicine, 142, 1183–1185.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.